T1	Participants 121 149	acute promyelocytic leukemia
T2	Participants 199 233	acute promyelocytic leukemia (APL)
T3	Participants 703 883	previously untreated adult APL patients registered to protocol INT 0129 by the Eastern Cooperative Oncology Group, the Southwest Oncology Group, and the Cancer and Leukemia Group B
T4	Participants 888 917	279 clinically eligible cases
T5	Participants 2419 2431	APL patients
